Skip to main content
Top
Published in: Calcified Tissue International 4/2019

01-04-2019 | Hypoparathyroidism | Original Research

Effect of Endogenous Parathyroid Hormone on Bone Geometry and Skeletal Microarchitecture

Authors: A Ram Hong, Ji Hyun Lee, Jung Hee Kim, Sang Wan Kim, Chan Soo Shin

Published in: Calcified Tissue International | Issue 4/2019

Login to get access

Abstract

Parathyroid hormone (PTH) has anabolic or catabolic effects on bones; however, the skeletal effect of endogenous PTH on cortical and trabecular bones is not yet clear. Therefore, we aimed to examine the effects of an excess and a deficiency of endogenous PTH on the lumbar spine trabecular bone score (TBS) and bone geometry using dual-energy X-ray absorptiometry. We retrospectively included 70 patients with primary hyperparathyroidism (PHPT), 26 patients with idiopathic or postoperative hypoparathyroidism (HypoPT), and 96 normal controls matched by age, sex, and body mass index. The bone mineral density (BMD) at the lumbar spine, femur neck, and total hip was higher in the HypoPT, followed by the controls and PHPT group (all P < 0.001). The TBS was significantly decreased in the PHPT group compared to the controls (P = 0.021); however, statistical significance disappeared after adjusting for the lumbar BMD (P = 0.653). There were no significant differences in the TBS between the HypoPT group and controls as well as the PHPT and HypoPT group. As for bone geometry parameters, the cross-sectional area, cross-sectional moment of inertia, and section modulus were higher in the HypoPT, followed by the controls and PHPT group (all P < 0.001); statistical significance remained after adjusting for the total hip BMD. We also observed a significantly increased cortical neck width in the HypoPT group compared to the PHPT group (P = 0.009). The buckling ratio was higher in the PHPT than the HypoPT group and controls (P = 0.018 and P = 0.013, respectively). The present study demonstrated that an excess of endogenous PTH had catabolic effects on both cortical and trabecular bones. Under conditions of endogenous PTH deficiency, the effect on cortical bone was pronounced, but that on trabecular bone was modest.
Literature
2.
go back to reference Cosman F, Lindsay R (1998) Is parathyroid hormone a therapeutic option for osteoporosis? A review of the clinical evidence. Calcif Tissue Int 62:475–480CrossRefPubMed Cosman F, Lindsay R (1998) Is parathyroid hormone a therapeutic option for osteoporosis? A review of the clinical evidence. Calcif Tissue Int 62:475–480CrossRefPubMed
3.
go back to reference Neer RM, Arnaud CD, Zanchetta JR et al (2001) Effect of parathyroid hormone (1–34) on fractures and bone mineral density in postmenopausal women with osteoporosis. N Engl J Med 344:1434–1441CrossRefPubMed Neer RM, Arnaud CD, Zanchetta JR et al (2001) Effect of parathyroid hormone (1–34) on fractures and bone mineral density in postmenopausal women with osteoporosis. N Engl J Med 344:1434–1441CrossRefPubMed
4.
go back to reference Chen Q, Kaji H, Iu MF, Nomura R, Sowa H, Yamauchi M, Tsukamoto T, Sugimoto T, Chihara K (2003) Effects of an excess and a deficiency of endogenous parathyroid hormone on volumetric bone mineral density and bone geometry determined by peripheral quantitative computed tomography in female subjects. J Clin Endocrinol Metab 88:4655–4658CrossRefPubMed Chen Q, Kaji H, Iu MF, Nomura R, Sowa H, Yamauchi M, Tsukamoto T, Sugimoto T, Chihara K (2003) Effects of an excess and a deficiency of endogenous parathyroid hormone on volumetric bone mineral density and bone geometry determined by peripheral quantitative computed tomography in female subjects. J Clin Endocrinol Metab 88:4655–4658CrossRefPubMed
5.
go back to reference Silverberg SJ, Shane E, de la Cruz L et al (1989) Skeletal disease in primary hyperparathyroidism. J Bone Miner Res 4:283–291CrossRefPubMed Silverberg SJ, Shane E, de la Cruz L et al (1989) Skeletal disease in primary hyperparathyroidism. J Bone Miner Res 4:283–291CrossRefPubMed
6.
go back to reference Parisien M, Cosman F, Mellish RW et al (1995) Bone structure in postmenopausal hyperparathyroid, osteoporotic, and normal women. J Bone Miner Res 10:1393–1399CrossRefPubMed Parisien M, Cosman F, Mellish RW et al (1995) Bone structure in postmenopausal hyperparathyroid, osteoporotic, and normal women. J Bone Miner Res 10:1393–1399CrossRefPubMed
7.
go back to reference Mitchell DM, Regan S, Cooley MR, Lauter KB, Vrla MC, Becker CB, Burnett-Bowie SA, Mannstadt M (2012) Long-term follow-up of patients with hypoparathyroidism. J Clin Endocrinol Metab 97:4507–4514CrossRefPubMedPubMedCentral Mitchell DM, Regan S, Cooley MR, Lauter KB, Vrla MC, Becker CB, Burnett-Bowie SA, Mannstadt M (2012) Long-term follow-up of patients with hypoparathyroidism. J Clin Endocrinol Metab 97:4507–4514CrossRefPubMedPubMedCentral
8.
go back to reference Laway BA, Goswami R, Singh N, Gupta N, Seith A (2006) Pattern of bone mineral density in patients with sporadic idiopathic hypoparathyroidism. Clin Endocrinol (Oxf) 64:405–409 Laway BA, Goswami R, Singh N, Gupta N, Seith A (2006) Pattern of bone mineral density in patients with sporadic idiopathic hypoparathyroidism. Clin Endocrinol (Oxf) 64:405–409
9.
go back to reference Rubin MR, Dempster DW, Zhou H, Shane E, Nickolas T, Sliney J Jr, Silverberg SJ, Bilezikian JP (2008) Dynamic and structural properties of the skeleton in hypoparathyroidism. J Bone Miner Res 23:2018–2024CrossRefPubMedPubMedCentral Rubin MR, Dempster DW, Zhou H, Shane E, Nickolas T, Sliney J Jr, Silverberg SJ, Bilezikian JP (2008) Dynamic and structural properties of the skeleton in hypoparathyroidism. J Bone Miner Res 23:2018–2024CrossRefPubMedPubMedCentral
10.
go back to reference Sikjaer T, Rejnmark L, Rolighed L, Heickendorff L, Mosekilde L (2011) The effect of adding PTH(1–84) to conventional treatment of hypoparathyroidism: a randomized, placebo-controlled study. J Bone Miner Res 26:2358–2370CrossRefPubMed Sikjaer T, Rejnmark L, Rolighed L, Heickendorff L, Mosekilde L (2011) The effect of adding PTH(1–84) to conventional treatment of hypoparathyroidism: a randomized, placebo-controlled study. J Bone Miner Res 26:2358–2370CrossRefPubMed
11.
go back to reference Chan FK, Tiu SC, Choi KL, Choi CH, Kong AP, Shek CC (2003) Increased bone mineral density in patients with chronic hypoparathyroidism. J Clin Endocrinol Metab 88:3155–3159CrossRefPubMed Chan FK, Tiu SC, Choi KL, Choi CH, Kong AP, Shek CC (2003) Increased bone mineral density in patients with chronic hypoparathyroidism. J Clin Endocrinol Metab 88:3155–3159CrossRefPubMed
12.
go back to reference Abugassa S, Nordenstrom J, Eriksson S, Sjoden G (1993) Bone mineral density in patients with chronic hypoparathyroidism. J Clin Endocrinol Metab 76:1617–1621PubMed Abugassa S, Nordenstrom J, Eriksson S, Sjoden G (1993) Bone mineral density in patients with chronic hypoparathyroidism. J Clin Endocrinol Metab 76:1617–1621PubMed
13.
go back to reference Stein EM, Silva BC, Boutroy S et al (2013) Primary hyperparathyroidism is associated with abnormal cortical and trabecular microstructure and reduced bone stiffness in postmenopausal women. J Bone Miner Res 28:1029–1040CrossRefPubMed Stein EM, Silva BC, Boutroy S et al (2013) Primary hyperparathyroidism is associated with abnormal cortical and trabecular microstructure and reduced bone stiffness in postmenopausal women. J Bone Miner Res 28:1029–1040CrossRefPubMed
14.
go back to reference Hansen S, Beck Jensen JE, Rasmussen L, Hauge EM, Brixen K (2010) Effects on bone geometry, density, and microarchitecture in the distal radius but not the tibia in women with primary hyperparathyroidism: a case-control study using HR-pQCT. J Bone Miner Res 25:1941–1947CrossRefPubMed Hansen S, Beck Jensen JE, Rasmussen L, Hauge EM, Brixen K (2010) Effects on bone geometry, density, and microarchitecture in the distal radius but not the tibia in women with primary hyperparathyroidism: a case-control study using HR-pQCT. J Bone Miner Res 25:1941–1947CrossRefPubMed
15.
go back to reference Cusano NE, Nishiyama KK, Zhang C, Rubin MR, Boutroy S, McMahon DJ, Guo XE, Bilezikian JP (2016) Noninvasive assessment of skeletal microstructure and estimated bone strength in hypoparathyroidism. J Bone Miner Res 31:308–316CrossRefPubMed Cusano NE, Nishiyama KK, Zhang C, Rubin MR, Boutroy S, McMahon DJ, Guo XE, Bilezikian JP (2016) Noninvasive assessment of skeletal microstructure and estimated bone strength in hypoparathyroidism. J Bone Miner Res 31:308–316CrossRefPubMed
16.
go back to reference Silva BC, Leslie WD, Resch H, Lamy O, Lesnyak O, Binkley N, McCloskey EV, Kanis JA, Bilezikian JP (2014) Trabecular bone score: a noninvasive analytical method based upon the DXA image. J Bone Miner Res 29:518–530CrossRefPubMed Silva BC, Leslie WD, Resch H, Lamy O, Lesnyak O, Binkley N, McCloskey EV, Kanis JA, Bilezikian JP (2014) Trabecular bone score: a noninvasive analytical method based upon the DXA image. J Bone Miner Res 29:518–530CrossRefPubMed
17.
go back to reference Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D (1999) A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of diet in Renal Disease Study Group. Ann Intern Med 130:461–470CrossRefPubMed Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D (1999) A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of diet in Renal Disease Study Group. Ann Intern Med 130:461–470CrossRefPubMed
18.
go back to reference Hong AR, Kim JH, Kim SW, Kim SY, Shin CS (2016) Trabecular bone score as a skeletal fragility index in acromegaly patients. Osteoporos Int 27:1123–1129CrossRefPubMed Hong AR, Kim JH, Kim SW, Kim SY, Shin CS (2016) Trabecular bone score as a skeletal fragility index in acromegaly patients. Osteoporos Int 27:1123–1129CrossRefPubMed
19.
go back to reference Broy SB, Cauley JA, Lewiecki ME, Schousboe JT, Shepherd JA, Leslie WD (2015) Fracture risk prediction by non-BMD DXA measures: the 2015 ISCD official positions part 1: hip geometry. J Clin Densitom 18:287–308CrossRefPubMed Broy SB, Cauley JA, Lewiecki ME, Schousboe JT, Shepherd JA, Leslie WD (2015) Fracture risk prediction by non-BMD DXA measures: the 2015 ISCD official positions part 1: hip geometry. J Clin Densitom 18:287–308CrossRefPubMed
20.
go back to reference Martin P, Bergmann P, Gillet C, Fuss M, Kinnaert P, Corvilain J, van Geertruyden J (1986) Partially reversible osteopenia after surgery for primary hyperparathyroidism. Arch Intern Med 146:689–691CrossRefPubMed Martin P, Bergmann P, Gillet C, Fuss M, Kinnaert P, Corvilain J, van Geertruyden J (1986) Partially reversible osteopenia after surgery for primary hyperparathyroidism. Arch Intern Med 146:689–691CrossRefPubMed
21.
go back to reference Rao DS, Wilson RJ, Kleerekoper M, Parfitt AM (1988) Lack of biochemical progression or continuation of accelerated bone loss in mild asymptomatic primary hyperparathyroidism: evidence for biphasic disease course. J Clin Endocrinol Metab 67:1294–1298CrossRefPubMed Rao DS, Wilson RJ, Kleerekoper M, Parfitt AM (1988) Lack of biochemical progression or continuation of accelerated bone loss in mild asymptomatic primary hyperparathyroidism: evidence for biphasic disease course. J Clin Endocrinol Metab 67:1294–1298CrossRefPubMed
22.
go back to reference Parisien M, Silverberg SJ, Shane E, de la Cruz L, Lindsay R, Bilezikian JP, Dempster DW (1990) The histomorphometry of bone in primary hyperparathyroidism: preservation of cancellous bone structure. J Clin Endocrinol Metab 70:930–938CrossRefPubMed Parisien M, Silverberg SJ, Shane E, de la Cruz L, Lindsay R, Bilezikian JP, Dempster DW (1990) The histomorphometry of bone in primary hyperparathyroidism: preservation of cancellous bone structure. J Clin Endocrinol Metab 70:930–938CrossRefPubMed
23.
go back to reference Brockstedt H, Christiansen P, Mosekilde L, Melsen F (1995) Reconstruction of cortical bone remodeling in untreated primary hyperparathyroidism and following surgery. Bone 16:109–117CrossRefPubMed Brockstedt H, Christiansen P, Mosekilde L, Melsen F (1995) Reconstruction of cortical bone remodeling in untreated primary hyperparathyroidism and following surgery. Bone 16:109–117CrossRefPubMed
24.
go back to reference Hansen S, Hauge EM, Rasmussen L, Jensen JE, Brixen K (2012) Parathyroidectomy improves bone geometry and microarchitecture in female patients with primary hyperparathyroidism: a one-year prospective controlled study using high-resolution peripheral quantitative computed tomography. J Bone Miner Res 27:1150–1158CrossRefPubMed Hansen S, Hauge EM, Rasmussen L, Jensen JE, Brixen K (2012) Parathyroidectomy improves bone geometry and microarchitecture in female patients with primary hyperparathyroidism: a one-year prospective controlled study using high-resolution peripheral quantitative computed tomography. J Bone Miner Res 27:1150–1158CrossRefPubMed
25.
go back to reference Vu TD, Wang XF, Wang Q et al (2013) New insights into the effects of primary hyperparathyroidism on the cortical and trabecular compartments of bone. Bone 55:57–63CrossRefPubMedPubMedCentral Vu TD, Wang XF, Wang Q et al (2013) New insights into the effects of primary hyperparathyroidism on the cortical and trabecular compartments of bone. Bone 55:57–63CrossRefPubMedPubMedCentral
26.
go back to reference Duan Y, De Luca V, Seeman E (1999) Parathyroid hormone deficiency and excess: similar effects on trabecular bone but differing effects on cortical bone. J Clin Endocrinol Metab 84:718–722CrossRefPubMed Duan Y, De Luca V, Seeman E (1999) Parathyroid hormone deficiency and excess: similar effects on trabecular bone but differing effects on cortical bone. J Clin Endocrinol Metab 84:718–722CrossRefPubMed
27.
go back to reference Silva BC, Boutroy S, Zhang C et al (2013) Trabecular bone score (TBS)--a novel method to evaluate bone microarchitectural texture in patients with primary hyperparathyroidism. J Clin Endocrinol Metab 98:1963–1970CrossRefPubMedPubMedCentral Silva BC, Boutroy S, Zhang C et al (2013) Trabecular bone score (TBS)--a novel method to evaluate bone microarchitectural texture in patients with primary hyperparathyroidism. J Clin Endocrinol Metab 98:1963–1970CrossRefPubMedPubMedCentral
28.
go back to reference Eller-Vainicher C, Filopanti M, Palmieri S et al (2013) Bone quality, as measured by trabecular bone score, in patients with primary hyperparathyroidism. Eur J Endocrinol 169:155–162CrossRefPubMed Eller-Vainicher C, Filopanti M, Palmieri S et al (2013) Bone quality, as measured by trabecular bone score, in patients with primary hyperparathyroidism. Eur J Endocrinol 169:155–162CrossRefPubMed
29.
go back to reference Romagnoli E, Cipriani C, Nofroni I et al (2013) “Trabecular Bone Score” (TBS): an indirect measure of bone micro-architecture in postmenopausal patients with primary hyperparathyroidism. Bone 53:154–159CrossRefPubMed Romagnoli E, Cipriani C, Nofroni I et al (2013) “Trabecular Bone Score” (TBS): an indirect measure of bone micro-architecture in postmenopausal patients with primary hyperparathyroidism. Bone 53:154–159CrossRefPubMed
30.
go back to reference Silva BCCN, Zhang C et al (2013) Beneficial effects of PTH (1–84) in hypoparathyroidism as determined by microarchitectural texture assessment (TBS): a 4-year experience. J Bone Miner Res 28(Suppl 1):FR0172 Silva BCCN, Zhang C et al (2013) Beneficial effects of PTH (1–84) in hypoparathyroidism as determined by microarchitectural texture assessment (TBS): a 4-year experience. J Bone Miner Res 28(Suppl 1):FR0172
31.
go back to reference Park HS, Seo DH, Rhee Y, Lim SK (2017) Site-specific difference of bone geometry indices in hypoparathyroid patients. Endocrinol Metab (Seoul) 32:68–76CrossRef Park HS, Seo DH, Rhee Y, Lim SK (2017) Site-specific difference of bone geometry indices in hypoparathyroid patients. Endocrinol Metab (Seoul) 32:68–76CrossRef
32.
go back to reference Rolighed L, Rejnmark L, Christiansen P (2014) Bone involvement in primary hyperparathyroidism and changes after parathyroidectomy. Eur Endocrinol 10:84–87CrossRefPubMedPubMedCentral Rolighed L, Rejnmark L, Christiansen P (2014) Bone involvement in primary hyperparathyroidism and changes after parathyroidectomy. Eur Endocrinol 10:84–87CrossRefPubMedPubMedCentral
33.
go back to reference Dempster DW, Parisien M, Silverberg SJ et al (1999) On the mechanism of cancellous bone preservation in postmenopausal women with mild primary hyperparathyroidism. J Clin Endocrinol Metab 84:1562–1566PubMed Dempster DW, Parisien M, Silverberg SJ et al (1999) On the mechanism of cancellous bone preservation in postmenopausal women with mild primary hyperparathyroidism. J Clin Endocrinol Metab 84:1562–1566PubMed
34.
go back to reference Piedra M, Garcia-Unzueta MT, Berja A, Paule B, Lavin BA, Valero C, Riancho JA, Amado JA (2011) Single nucleotide polymorphisms of the OPG/RANKL system genes in primary hyperparathyroidism and their relationship with bone mineral density. BMC Med Genet 12:168CrossRefPubMedPubMedCentral Piedra M, Garcia-Unzueta MT, Berja A, Paule B, Lavin BA, Valero C, Riancho JA, Amado JA (2011) Single nucleotide polymorphisms of the OPG/RANKL system genes in primary hyperparathyroidism and their relationship with bone mineral density. BMC Med Genet 12:168CrossRefPubMedPubMedCentral
35.
go back to reference Vestergaard P, Mollerup CL, Frokjaer VG, Christiansen P, Blichert-Toft M, Mosekilde L (2000) Cohort study of risk of fracture before and after surgery for primary hyperparathyroidism. Bmj 321:598–602CrossRefPubMedPubMedCentral Vestergaard P, Mollerup CL, Frokjaer VG, Christiansen P, Blichert-Toft M, Mosekilde L (2000) Cohort study of risk of fracture before and after surgery for primary hyperparathyroidism. Bmj 321:598–602CrossRefPubMedPubMedCentral
36.
go back to reference Vestergaard P, Mosekilde L (2003) Fractures in patients with primary hyperparathyroidism: nationwide follow-up study of 1201 patients. World J Surg 27:343–349CrossRefPubMed Vestergaard P, Mosekilde L (2003) Fractures in patients with primary hyperparathyroidism: nationwide follow-up study of 1201 patients. World J Surg 27:343–349CrossRefPubMed
37.
go back to reference Khosla S, Melton LJ III, Wermers RA, Crowson CS, O’Fallon W, Riggs B (1999) Primary hyperparathyroidism and the risk of fracture: a population-based study. J Bone Miner Res 14:1700–1707CrossRefPubMed Khosla S, Melton LJ III, Wermers RA, Crowson CS, O’Fallon W, Riggs B (1999) Primary hyperparathyroidism and the risk of fracture: a population-based study. J Bone Miner Res 14:1700–1707CrossRefPubMed
38.
go back to reference De Geronimo S, Romagnoli E, Diacinti D, D’Erasmo E, Minisola S (2006) The risk of fractures in postmenopausal women with primary hyperparathyroidism. Eur J Endocrinol 155:415–420CrossRefPubMed De Geronimo S, Romagnoli E, Diacinti D, D’Erasmo E, Minisola S (2006) The risk of fractures in postmenopausal women with primary hyperparathyroidism. Eur J Endocrinol 155:415–420CrossRefPubMed
39.
go back to reference Vignali E, Viccica G, Diacinti D et al (2009) Morphometric vertebral fractures in postmenopausal women with primary hyperparathyroidism. J Clin Endocrinol Metab 94:2306–2312CrossRefPubMedPubMedCentral Vignali E, Viccica G, Diacinti D et al (2009) Morphometric vertebral fractures in postmenopausal women with primary hyperparathyroidism. J Clin Endocrinol Metab 94:2306–2312CrossRefPubMedPubMedCentral
40.
go back to reference Underbjerg L, Sikjaer T, Mosekilde L, Rejnmark L (2015) The Epidemiology of Nonsurgical Hypoparathyroidism in Denmark: A Nationwide Case Finding Study. J Bone Miner Res 30:1738–1744CrossRefPubMed Underbjerg L, Sikjaer T, Mosekilde L, Rejnmark L (2015) The Epidemiology of Nonsurgical Hypoparathyroidism in Denmark: A Nationwide Case Finding Study. J Bone Miner Res 30:1738–1744CrossRefPubMed
41.
go back to reference Underbjerg L, Sikjaer T, Mosekilde L, Rejnmark L (2014) Postsurgical hypoparathyroidism–risk of fractures, psychiatric diseases, cancer, cataract, and infections. J Bone Miner Res 29:2504–2510CrossRefPubMed Underbjerg L, Sikjaer T, Mosekilde L, Rejnmark L (2014) Postsurgical hypoparathyroidism–risk of fractures, psychiatric diseases, cancer, cataract, and infections. J Bone Miner Res 29:2504–2510CrossRefPubMed
42.
go back to reference Kim KM, Choi SH, Lim S, Moon JH, Kim JH, Kim SW, Jang HC, Shin CS (2014) Interactions between dietary calcium intake and bone mineral density or bone geometry in a low calcium intake population (KNHANES IV 2008–2010). J Clin Endocrinol Metab 99:2409–2417CrossRefPubMed Kim KM, Choi SH, Lim S, Moon JH, Kim JH, Kim SW, Jang HC, Shin CS (2014) Interactions between dietary calcium intake and bone mineral density or bone geometry in a low calcium intake population (KNHANES IV 2008–2010). J Clin Endocrinol Metab 99:2409–2417CrossRefPubMed
Metadata
Title
Effect of Endogenous Parathyroid Hormone on Bone Geometry and Skeletal Microarchitecture
Authors
A Ram Hong
Ji Hyun Lee
Jung Hee Kim
Sang Wan Kim
Chan Soo Shin
Publication date
01-04-2019
Publisher
Springer US
Published in
Calcified Tissue International / Issue 4/2019
Print ISSN: 0171-967X
Electronic ISSN: 1432-0827
DOI
https://doi.org/10.1007/s00223-019-00517-0

Other articles of this Issue 4/2019

Calcified Tissue International 4/2019 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine